Microchip Biotechnologies Reels in $18.1M in Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Microchip Biotechnologies, which has developed a sample prep system for Sanger and next-generation sequencing, has received $18.1 million in series B financing from previous and new investors.

New investors include Domain Associates, Samsung Ventures, Western Technology Investment, and undisclosed individual investors; and previous investors Rona Syndicates and In-Q-Tel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.